Mar 15, 2023 04:05PM
Mar 15, 2023 04:05PM
Mar 1, 2023 04:05PM
Mar 1, 2023 04:05PM
Nov 9, 2022 04:05PM
Nov 9, 2022 04:05PM
Oct 11, 2022 07:01AM DICE Therapeutics (DICE) Reports Positive Topline Data from Phase 1 Clinical Trial of DC-806
Oct 11, 2022 07:00AM
Oct 11, 2022 07:00AM
Sep 12, 2022 08:16AM
Aug 11, 2022 04:10PM
Aug 11, 2022 04:10PM
Jul 21, 2022 04:05PM
Jul 21, 2022 04:05PM DICE Therapeutics Announces Completion of Enrollment in Phase 1 Clinical Trial of Lead Oral IL-17 Antagonist, DC-806, for the Treatment of Psoriasis
Jul 18, 2022 06:26AM
May 12, 2022 04:05PM
May 12, 2022 04:05PM
Mar 21, 2022 04:05PM
Mar 21, 2022 04:05PM
Nov 12, 2021 08:00AM
Nov 12, 2021 08:00AM DICE Therapeutics Reports Third Quarter 2021 Financial Results and Recent Highlights
Oct 25, 2021 08:00AM
Oct 25, 2021 08:00AM

322,209 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All